Fund Holdings5AM Venture Management, LLC

Total Portfolio Value
$347.54M
Total Bought
$28.42M
Total Sold
$51.11M
Net Transaction
-$22.68M
Filing Period:
Securities
SharesValue ($K)
Q2 2023
Q3 2023
Change
Q2 2023
Q3 2023
Weight (%)
Change
DIANTHUS THERAPEUTICS INC(DNTH)01,472,264+1,472,264020,1265.79%+20,126
TYRA BIOSCIENCES INC(TYRA)0411,450+411,45005,6661.63%+5,666
PHARVARIS N V
COM
587,600587,60008,89612,2633.53%+3,367
ENTRADA THERAPEUTICS INC4,408,3794,408,379066,74369,65220.04%+2,910
GH RESEARCH PLC(GHRS)152,022404,404+252,3821,8044,0641.17%+2,261
MIRATI THERAPEUTICS INC192,500192,50006,9558,3852.41%+1,430
HOMOLOGY MEDICINES INC4,535,9194,535,91904,0145,3071.53%+1,293
SPRUCE BIOSCIENCES INC2,364,0002,364,00005,0835,3431.54%+260
CIDARA THERAPEUTICS INC1,134,5111,134,51101,2821,0690.31%-213
VIRIDIAN THERAPEUTICS INC(VRDN)280,000410,000+130,0006,6616,2891.81%-372
MOONLAKE IMMUNOTHERAPEUTICS(MLTX)357,486313,210-44,27618,23217,8535.14%-379
ANAPTYSBIO INC357,733357,73307,2766,4251.85%-851
DISC MEDICINE INC(IRON)488,442438,442-50,00021,68720,5985.93%-1,089
COGENT BIOSCIENCES INC(COGT)790,440790,44009,3597,7072.22%-1,652
ARVINAS INC320,000320,00007,9426,2851.81%-1,658
CRINETICS PHARMACEUTICALS IN(CRNX)862,286462,286-400,00015,53813,7483.96%-1,790
CELLDEX THERAPEUTICS INC NEW(CLDX)310,270310,270010,5278,5392.46%-1,989
IMPEL PHARMACEUTICALS INC2,884,7912,884,79103,6641,2400.36%-2,423
MERSANA THERAPEUTICS INC1,305,0001,305,00004,2931,6570.48%-2,636
VIKING THERAPEUTICS INC(VKTX)585,000585,00009,4836,4761.86%-3,007
AVIDITY BIOSCIENCES INC665,555665,55507,3814,2461.22%-3,135
SCPHARMACEUTICALS INC1,200,6471,200,647012,2358,5492.46%-3,686
ZENTALIS PHARMACEUTICALS INC490,000490,000013,8239,8292.83%-3,993
VOR BIOPHARMA INC(VOR)6,361,7236,361,723019,65813,4873.88%-6,171
RALLYBIO CORP3,630,7243,630,724020,55012,2363.52%-8,314
ENLIVEN THERAPEUTICS INC5,798,4755,160,975-637,500118,34770,49920.29%-47,848
Page 1 of 1